Status
Global HQ
New York, United States
Countries of investment
Investment stages
Industries
About
Scientia Ventures is dedicated to reshaping the funding landscape in life sciences through strategic investments in cutting-edge biopharmaceutical companies. With a strong emphasis on innovation, the firm actively supports the development of advanced therapeutic solutions, including proprietary Antibody Drug Conjugates aimed at revolutionizing cancer treatment. By fostering partnerships with visionary entrepreneurs and leveraging deep industry expertise, Scientia Ventures seeks to accelerate breakthroughs that address critical unmet medical needs. Our commitment to driving advancement in healthcare positions us as a pivotal player in the evolution of life sciences investment.
Scientia Ventures is dedicated to reshaping the funding landscape in life sciences through strategic investments in cutting-edge biopharmaceutical companies. With a strong emphasis on innovation, the firm actively supports the development of advanced therapeutic solutions, including proprietary Antibody Drug Conjugates aimed at revolutionizing cancer treatment. By fostering partnerships with visionary entrepreneurs and leveraging deep industry expertise, Scientia Ventures seeks to accelerate breakthroughs that address critical unmet medical needs. Our commitment to driving advancement in healthcare positions us as a pivotal player in the evolution of life sciences investment.
Investment Thesis
Manager's Experience
With a robust background in venture capital, the fund manager has actively engaged in over 50 deals, primarily targeting early-stage technology and healthcare sectors across North America and Europe. Demonstrating a data-driven approach, they have successfully executed notable exits, showcasing a knack for identifying high-potential startups. Their investment strategy emphasizes collaboration with operators, supporting entrepreneurs through mentorship and resources. This combination of sector expertise and hands-on management has positioned them as a formidable player in the venture landscape.
Scientia Ventures Contacts Information
Primary contact